Edition:
United Kingdom

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

2.26USD
8:01pm BST
Change (% chg)

$0.01 (+0.44%)
Prev Close
$2.25
Open
$2.25
Day's High
$2.44
Day's Low
$2.21
Volume
116,824
Avg. Vol
144,097
52-wk High
$11.41
52-wk Low
$0.83

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.469
Mar '18 0.00 -0.581
FY 2017 Dec '17 0.00 -0.634
Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 5 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.00 0.00 0.00 1.46
Year Ending Dec-19 4 1.10 4.40 0.00 4.40
Earnings (per share)
Quarter Ending Sep-18 5 -0.50 -0.41 -0.60 -0.90
Quarter Ending Dec-18 5 -0.47 -0.37 -0.60 -0.97
Year Ending Dec-18 5 -2.05 -1.86 -2.28 -2.52
Year Ending Dec-19 5 -2.38 -1.59 -3.37 -2.60
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.71 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 114.98 5.75
Price to Book (MRQ) 6.21 15.51 5.00
Price to Tangible Book (MRQ) 6.22 14.52 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 30.24 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.55 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -495.83 29.15 20.61
EPS (TTM) vs TTM 1 Yr. Ago -161.04 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 4.36 5.46 3.03
LT Debt to Equity (MRQ) 0.00 35.26 12.51
Total Debt to Equity (MRQ) 0.00 37.08 16.85
Interest Coverage (TTM) -- -102.35 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.64 10.68
Operating Margin (TTM) -- -759.75 4.32
Operating Margin - 5 Yr. Avg. -- -621.68 6.11
Pre-Tax Margin (TTM) -- -733.60 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.38 6.51
Net Profit Margin (TTM) -- -734.97 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.42 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,230,020 860,375,045
Net Income/Employee (TTM) -1,818,125 3,144,156 101,207,177
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.00 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -195.69 -0.16 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -580.12 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -3,285.30 3.29 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -66.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 41.29%
# of Holders: 45
Total Shares Held: 5,890,396
3 Mo. Net Change: 1,168,627
# New Positions: 17
# Closed Positions: 6
# Increased Positions: 25
# Reduced Positions: 13
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.